Pay in 4 interest-free payments of $5.61 Learn more
Ships within 48 hours · Estimated delivery Nov 4 - Nov 9
Based on the clinical trial population and the medications mechanism, individuals who may benefit most from retatrutide once it becomes available include: Adults with a BMI of 30 or greater (obesity) Adults with a BMI of 27 or greater who have weight-related conditions such as type 2 diabetes, hypertension, dyslipidemia, or sleep apnea Individuals who have not achieved adequate results with semaglutide or tirzepatide Patients seeking greater weight loss than what current medications provide Individuals with metabolic dysfunction-associated steatohepatitis (MASH) given the glucagon receptors role in liver fat metabolism Retatrutide may not be appropriate for individuals with a history of medullary thyroid carcinoma, multiple endocrine neoplasia type 2, severe gastrointestinal disorders, or a history of pancreatitis
GLP-1 users who work together with a RD have greater long-term weight-loss success than those who have to figure it out on their own
As of 2025, most large employers did not cover GLP-1 drugs for weight loss
Step 5: Listen to Your Body Pay attention to how you feel over the first few weeks
Point is you're getting the weight off!," said another
